Mechanisms for covalent binding of benoxaprofen glucuronide to human serum albumin. Studies By tandem mass spectrometry.

Tandem MS has been used to establish the structure and specific binding sites of covalent protein adducts formed upon incubation of the acyl glucuronide of the propionic acid nonsteroidal anti-inflammatory drug benoxaprofen with human serum albumin in vitro. Benoxaprofen 1-O-beta-glucuronide was enzymatically synthesized in vitro and incubated with human serum albumin both in the presence and in the absence of NaCNBH3. The modified human serum albumins were digested with trypsin and separated by HPLC. The modified peptides were detected using HPLC-electrospray MS (with selected-ion monitoring) and were structurally characterized by tandem MS using matrix-assisted laser desorption ionization in both the post-source decay and high-energy collision-induced dissociation modes. These studies established that benoxaprofen glucuronide forms covalent adducts with protein nucleophiles both by nucleophilic displacement of glucuronic acid at the anomeric center and by condensation of the rearranged acyl glucuronic acid isomers with epsilon-amino functions of lysine residues after acyl migration of the aglycone from the anomeric center. Lys-159 was identified as the major binding site. Thus, we have established that members of the less reactive propionic acid class of acyl glucuronides, such as the glucuronide of benoxaprofen, are also capable of reacting with protein nucleophiles to form covalent adducts analogous to those of tolmetin glucuronide (tolmetin is an acetic acid nonsteroidal anti-inflammatory drug), via the mechanisms previously reported from this laboratory, and that the specific covalent binding site profile appears to be drug dependent.

[1]  H. W. Ruelius,et al.  Interactions between oxaprozin glucuronide and human serum albumin. , 1987, Xenobiotica; the fate of foreign compounds in biological systems.

[2]  A. Burlingame,et al.  Rapid mass spectrometric peptide sequencing and mass matching for characterization of human melanoma proteins isolated by two-dimensional PAGE. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Alma L. Burlingame,et al.  The Advantages and Versatility of a High-Energy Collision-Induced Dissociation-Based Strategy for the Sequence and Structural Determination of Proteins , 1994 .

[4]  C. Fenselau,et al.  Reaction of bilirubin glucuronides with serum albumin. , 1986, Journal of chromatography.

[5]  D. C. Carter,et al.  Atomic structure and chemistry of human serum albumin , 1993, Nature.

[6]  L. Benet,et al.  Acyl glucuronides revisited: is the glucuronidation process a toxification as well as a detoxification mechanism? , 1992, Drug metabolism reviews.

[7]  A. Burlingame,et al.  Peptide sequence determination by matrix-assisted laser desorption ionization employing a tandem double focusing magnetic—Orthogonal acceleration time-of-flight mass spectrometer , 1996, Journal of the American Society for Mass Spectrometry.

[8]  A. Burlingame,et al.  Evidence for covalent binding of acyl glucuronides to serum albumin via an imine mechanism as revealed by tandem mass spectrometry. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[9]  H. Zimmerman,et al.  Idiosyncratic liver toxicity of nonsteroidal antiinflammatory drugs: molecular mechanisms and pathology. , 1995, Critical reviews in toxicology.

[10]  K. Biemann Contributions of mass spectrometry to peptide and protein structure. , 1988, Biomedical & environmental mass spectrometry.

[11]  S. Kirkman,et al.  Reactions of oxaprozin-1-O-acyl glucuronide in solutions of human plasma and albumin. , 1986, Advances in experimental medicine and biology.

[12]  T. W. Wu,et al.  Origin of mammalian biliprotein and rearrangement of bilirubin glucuronides in vivo in the rat. , 1984, The Journal of clinical investigation.

[13]  P. Roepstorff,et al.  Proposal for a common nomenclature for sequence ions in mass spectra of peptides. , 1984, Biomedical mass spectrometry.

[14]  E M Faed,et al.  Properties of acyl glucuronides: implications for studies of the pharmacokinetics and metabolism of acidic drugs. , 1984, Drug metabolism reviews.

[15]  R. Brodersen,et al.  Albumin binding of anti-inflammatory drugs. Utility of a site-oriented versus a stoichiometric analysis. , 1984, Molecular pharmacology.

[16]  L. Benet,et al.  Hypersensitivity to nonsteroidal anti-inflammatory drugs , 1995, Nature Medicine.

[17]  A. Burlingame,et al.  Protein sequence and structural studies employing matrix-assisted laser desorption ionization-high energy collision-induced dissociation , 1997 .

[18]  L. Benet,et al.  Irreversible binding of zomepirac to plasma protein in vitro and in vivo. , 1986, The Journal of clinical investigation.

[19]  C. Fenselau,et al.  Acylation of albumin by 1-O-acyl glucuronides. , 1985, Drug metabolism and disposition: the biological fate of chemicals.

[20]  A. Burlingame,et al.  Reactivity of tolmetin glucuronide with human serum albumin. Identification of binding sites and mechanisms of reaction by tandem mass spectrometry. , 1995, Drug metabolism and disposition: the biological fate of chemicals.

[21]  J. Hodge,et al.  The Amadori rearrangement. , 1955, Advances in carbohydrate chemistry.

[22]  D. Chatfield,et al.  Disposition and metabolism of benoxaprofen in laboratory animals and man. , 1978, Xenobiotica; the fate of foreign compounds in biological systems.

[23]  L. Benet,et al.  Covalent binding of zomepirac glucuronide to proteins: evidence for a Schiff base mechanism. , 1990, Drug metabolism and disposition: the biological fate of chemicals.

[24]  R. N. Macsween,et al.  JAUNDICE ASSOCIATED WITH THE USE OF BENOXAPROFEN , 1982, The Lancet.